Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Prescription Drugs & Other Medical Products

Reports

Displaying 1 - 10 of 218. 10 per page. Page 1.

Advanced Search
ASPE Data Point

The U.S. Age-Adjusted Death Rate Reached a Record Low in 2025: What Drove the Decline?

KEY POINTSCDC reported a provisional 2025 age-adjusted death rate of 689.2 deaths per 100,000 population, the lowest ever reported death rate and 4.6% below the final 2024 rate of 722.1 deaths per 100,000 population.CDC notes that the published 2024 and 2025 rates u
Research Brief

Children in Child Welfare are More Likely to be Prescribed Psychotropic Medication than Other Children on Medicaid: Findings from Florida and Kentucky

The use of psychotropic medications in children is a complex issue for parents, caregivers, health care professionals, researchers, and policymakers. Psychotropic medications are used to treat behavioral health conditions. When these medications are prescribed appropriately, they can be effective in managing behavioral health symptoms.
Research Brief

Estimating Emergency Department Utilization of Select Drugs during Extreme Heat Events

We modeled the excess utilization of three commonly used drugs that treat heat-related illness in emergency departments during extreme heat events, using literature-derived estimates of emergency department visit rates for heat-related illness on extreme heat days and drug utilization rates from medical claims data.We estimate that extreme heat is associated with an average of 34,
Report

Defining and Measuring the Resilience, Criticality, and Vulnerability of Medical Product Supply Chains

Recent disruptions in medical product supply chains have highlighted the need for stronger, more coordinated approaches to ensuring reliable access to medical products.
ASPE Issue Brief

Measuring Innovation of Medical Products

Increasing innovation in medical products is a policy priority. A first step to understanding changes in the level of innovation is to determine how to measure the baseline of innovation. Existing research employs a variety of measurement methods–scientific, therapeutic, and economic measures–to study trends in medical product (e.g., drugs, biologics, devices) innovation.
Report

Understanding the Role of Patient Advocacy Organizations in Funding Medical Product Research and Development

Patient advocacy organizations (PAOs) play a key role in medical product development. Many PAOs raise money to fund medical product development activities – such as basic science research, preclinical research, and clinical trials - for their condition of focus, whereas others fund or develop resources such as biobanks or patient registries to support the research community.
Report

U.S. Biosimilar Market Entry Challenges and Facilitating Factors

There is ongoing interest in understanding ways to reduce drug prices and improve patient access to prescription drugs in the U.S. The estimated savings to the U.S. healthcare system from the use of biosimilars are significant.